Dr Duncan Sutherland, a distinguished nuclear medicine specialist, is dedicated to utilizing advanced diagnostic and therapeutic techniques to improve patient outcomes. His clinical expertise encompasses the use of positron emission tomography (PET) and single-photon emission computed tomography (SPECT) for precise imaging of oncological, cardiovascular, and neurological conditions. Dr Sutherland is particularly skilled in radioisotope therapies, including the application of targeted radionuclide therapy for metastatic cancers and hyperthyroidism. He has a special interest in molecular imaging, leveraging radiopharmaceuticals to detect early-stage diseases and monitor treatment efficacy with unparalleled accuracy. Passionate about advancing the field, Dr Sutherland stays at the forefront of nuclear medicine innovations, ensuring patients benefit from the latest evidence-based approaches. If you have experienced Dr Sutherland's expert care and dedication, your feedback would be invaluable and could guide others in seeking high-quality nuclear medicine services.